Low expression of ALDH1A2 is an unfavorable prognostic biomarker for survival in PCa,128 HNSCC,129 breast cancer,130, 131 ovarian cancer,132 and CC133 patients. Here, ALDH1A2 is linked to posterior cortical atrophy.